Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
237.29
-3.86 (-1.60%)
Apr 19, 2024, 11:03 AM EDT - Market open

Inspire Medical Systems Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
185.54441.59214.47190.5222.8697.298.968.96
Short-Term Investments
274.849.82043.84126.6190.927.197.19
Cash & Cash Equivalents
460.38451.41214.47234.36149.47188.2116.1416.14
Cash Growth
1.99%110.48%-8.49%56.80%-20.59%1065.89%0%-
Receivables
89.8861.2334.1825.0613.136.673.863.86
Inventory
33.8911.8917.238.485.832.673.673.67
Other Current Assets
9.65.512.661.972.211.730.430.43
Total Current Assets
593.74530.03268.54269.87170.64199.2824.124.1
Property, Plant & Equipment
62.6524.1316.4111.123.960.80.990.99
Long-Term Investments
9.1409.9406.28000
Other Long-Term Assets
11.2810.720.20.20.38000
Total Long-Term Assets
83.0734.8426.5511.3210.620.80.990.99
Total Assets
676.81564.88295.08281.19181.25200.0825.0925.09
Accounts Payable
38.8426.8511.677.214.463.4333
Current Debt
009.1900000
Other Current Liabilities
39.2734.3420.4513.5212.47.734.154.15
Total Current Liabilities
78.1161.1941.3120.7316.8611.167.157.15
Long-Term Debt
24.857.5424.630.6324.5224.9316.4616.46
Other Long-Term Liabilities
1.350.150.130.090.0400.160.16
Total Long-Term Liabilities
26.197.6824.7330.7224.5624.9316.6216.62
Total Liabilities
104.368.8766.0451.4441.4236.0823.7623.76
Total Debt
24.857.5433.7830.6324.5224.9316.4616.46
Debt Growth
229.70%-77.69%10.29%24.92%-1.62%51.43%--
Retained Earnings
-345.42-324.27-279.39-237.35-180.16-146.91-125.09-125.09
Comprehensive Income
0.8-0.09-0.060.030.1-0.0500
Shareholders' Equity
572.51496.01229.05229.75139.841641.331.33
Net Cash / Debt
435.53443.88180.68203.73124.94163.28-0.32-0.32
Net Cash / Debt Growth
-1.88%145.66%-11.31%63.06%-23.48%---
Net Cash Per Share
14.8615.816.637.815.2511.20-0.27-0.29
Working Capital
515.63468.85227.23249.14153.78188.1216.9516.95
Book Value Per Share
19.5417.678.408.815.8711.251.131.21
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).